Abstract:From 2002 to 2004 senile plaques were selected from hippocampus of 6 patients with senile dementia, including 3 males and 3 females, aged from 60-81 years, in Geriatrics Institutes, Affiliated Hospital of Anhui Medical University. Delay time after death was shorter than 8 hours. According to NINCDS-ADRDA standard, they were diagnosed as having senile dementia after other dementia was excluded, combing with the history of disease and laboratory examination. On the basis of CERAD standard, senile plaques and neurofibrillary tangles appeared widely in hippocampus and cortex of temporal lobe. It was Ⅵ grade in Braak rating. Eleven transgenic mice with senile dementia, aged 11 months, 5 males and 6 females, were selected. The senile plaques in hippocampus were measured in 6 patients with senile dementia and 11 transgenic mice with serial section method combined with modified Bielshowsky silver staining and immunohistochemical method, respectively. The classic results showed that various senile plaques appeared in the two methods. The classic plaques were round, with clear boundary. There was a transparent areola around the core. Outer ring contained amyloid and argentophilic fibers of different caliber. Diffuse plaque was with obscure boundary compared with the classic plaques. The plaque was composed of amyloid and tenuous mesh argyrophilic structure. ②The different cross-section of classic plaque was different in form, whereas the diffuse plaque was in similar structure. ③In transgenic mice with senile dementia, there was no classic plaque, but a few diffuse plaques. Distinct loss had appeared in synapsis of hippocampus and cortex of temporal lobe. Immunofluorescence staining had the best specificity and lightest background, followed by immunohistochemistical staining. Argentation had better sensitivity, but with worse specificity and the darkest staining background.

Characteristics and Application of Transgenic Mouse Models in Alzheimer's Disease

Advance on Research of Alzheimer Disease Transgenic Mice Model

Current Status of Genetic Engineering Mouse Models of Alzheimer's Disease

Characteristics of senile plaques in the hippocampus of patients with senile dementia and transgenic mice

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Critical thinking of Alzheimer's transgenic mouse model: current research and future perspective

Mouse Models of Alzheimer’s Disease

Insights on the Use of Transgenic Mice Models in Alzheimer's Disease Research

Establishment and Evaluation of Transgenic Models of Alzheimer's Disease with Senescence Accelerated Background

Updates on mouse models of Alzheimer's disease

APP mouse models for Alzheimer's disease preclinical studies

Updates on Mouse Models of Alzheimer’s Disease

[The Comparative Study on High Field MRI and Pathology of Alzheimer's Disease Transgenic Mice].

Animal Models of Alzheimer's Disease: Current Strategies and New Directions.

Praxiological,neurobiochemical and pathological characteristics of experimental animal model of Alzheimer's disease

Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer's disease

Animal models of Alzheimer's disease: Applications, evaluation, and perspectives

Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease

Modeling Alzheimer’s Disease in Mouse without Mutant Protein Overexpression: Cooperative and Independent Effects of Aβ and Tau

Alzheimer’s disease: experimental models and reality

Pathophysiologic abnormalities in transgenic mice carrying the Alzheimer disease PSEN1 Δ440 mutation